Top compounds associated with response to C6orf163

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	JQ-1:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.013	0.7
mRNA	SN-38	CTRPv2	pan-cancer	AAC	0.014	0.7
mRNA	thalidomide	CTRPv2	pan-cancer	AAC	0.021	0.7
mRNA	Erlotinib	UHNBreast	pan-cancer	AAC	0.11	0.7
mRNA	Mitomycin-C	CTRPv2	pan-cancer	AAC	0.012	0.7
mRNA	CHEMBL1222381	CTRPv2	pan-cancer	AAC	0.012	0.7
mRNA	lapatinib	gCSI	pan-cancer	AAC	0.02	0.7
mRNA	Gemcitabine	CTRPv2	pan-cancer	AAC	0.012	0.7
mRNA	AT7867	CTRPv2	pan-cancer	AAC	0.013	0.7
mRNA	selumetinib:GDC-0941 (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.012	0.7

Download CSV